On July 25, Guangzhou Wondfo Health Technology Co., Ltd. (hereinafter referred to as Wondfo Health), a subsidiary of Wondfo Biotech, held the grand opening ceremony of its Malaysia branch in Kuala Lumpur. This marks a significant milestone in Wondfo Health’s efforts to deepen its presence in Southeast Asia and accelerate its global strategy. It also reflects China’s “Belt and Road” initiative by promoting high-quality healthcare services abroad.

As Wondfo’s dedicated home health subsidiary, Wondfo Health extends medical-grade diagnostics to personal and family use. It provides rapid testing solutions in fertility, sexual health, respiratory health, blood glucose monitoring, and more.



At the ceremony, Prof. Ji Hua Wang, Chairwoman of Wondfo, delivered a speech expressing her support for the initiative. Mrs. Yunping Peng, General Manager of Wondfo Health, also shared her gratitude for the support from all sectors.

The official launch of Wondfo Health in Malaysia highlights the value of localized operations and builds a strategic foundation for Chinese enterprises in Southeast Asia’s home health testing market. It will expand access to family diagnostics and enhance regional healthcare management—advancing biotechnology to benefit society.